U.S. FDA advisers vote in favor of Pfizer/BioNTech COVID-19 vaccine in young kids

(Reuters) – A panel of outside advisers to the U.S. Food and Drug Administration on Tuesday voted to recommend the Pfizer Inc and BioNTech SE COVID-19 vaccine for children ages five to 11 years.

(Reporting by Manas Mishra in Bengaluru; Editing by Bill Berkrot)